AstraZeneca antibody cocktail fails to prevent COVID-19, in small setback

AstraZeneca said Tuesday that a late-stage trial failed to provide evidence that its COVID-19 antibody therapy protected people who had contact with an infected person from the disease, a small setback in its efforts to find alternatives to vaccines.

Video Transcript

[MUSIC PLAYING]

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting